Efficacy and safety of rasagiline monotherapy in Japanese patients with early Parkinson's disease: A phase 3, randomized, double-blind, placebo-controlled, multicenter study

被引：0
|
作者：
Hattori, N. [1 ]
Takeda, A. [2 ]
Takeda, S. [3 ]
Nishimura, A. [3 ]
Kitagawa, T. [3 ]
Mochizuki, H. [4 ]
Nagai, M. [5 ]
Takahashi, R. [6 ]
机构：
[1] Juntendo Univ, Dept Neurol, Fac Med, Tokyo, Japan
[2] Natl Hosp Org Sendai Nishitaga Hosp, Dept Neurol, Sendai, Miyagi, Japan
[3] Takeda Pharmaceut Co Ltd, Japan Dev Ctr, Osaka, Japan
[4] Osaka Univ, Dept Neurol, Grad Sch Med, Osaka, Japan
[5] Ehime Univ Hosp, Clin Therapeut Trial Ctr, Toon, Ehime, Japan
[6] Kyoto Univ, Dept Neurol, Grad Sch Med, Kyoto, Japan
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2017年 / 381卷
关键词：
D O I：
10.1016/j.jns.2017.08.662
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
634
引用
收藏
页码：231 / 232
页数：2
相关论文
共 50 条
  • [21] Efficacy and Safety of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Crohn's Disease
    Chowla, Navreet M.
    Tariq, Raseen
    Aggarwal, Manik
    Loftus, Edward V.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S820 - S821
  • [22] A PHASE III, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF NEUCARDIN™ IN PATIENTS WITH CHRONIC HEART FAILURE
    Gao, Runlin
    Zhang, Jian
    Liu, Heping
    Wang, Lina
    Pang, Xiaohua
    Fu, Lu
    Meng, Fanbo
    Zhou, Mingdong
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 668 - 668
  • [23] Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
    Kinoshita, Yoshikazu
    Sakurai, Yuuichi
    Shiino, Madoka
    Kudou, Kentaro
    Nishimura, Akira
    Miyagi, Takuya
    Iwakiri, Katsuhiko
    Umegaki, Eiji
    Ashida, Kiyoshi
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2016, 81-82 : 1 - 7
  • [24] Efficacy and tolerability of transdermal nicotine patches in patients with Parkinson's disease: A randomized, double-blind, placebo-controlled study
    Vieregge, P
    Sieberer, M
    Jacobs, H
    Hagenah, J
    NEUROLOGY, 2000, 54 (07) : A278 - A278
  • [25] Efficacy and safety of ustekinumab in Japanese patients with severe atopic dermatitis: a randomized, double-blind, placebo-controlled, phase II study
    Saeki, H.
    Kabashima, K.
    Tokura, Y.
    Murata, Y.
    Shiraishi, A.
    Tamamura, R.
    Randazzo, B.
    Imanaka, K.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (02) : 419 - 427
  • [26] A placebo controlled, randomized, double-blind study to assess the safety and clinical benefit of rasagiline as an add-on to dopamine agonist monotherapy in early Parkinson's disease (PD): The ANDANTE study
    Hauser, R. A.
    Silver, D.
    Choudhry, A.
    Isaacson, S.
    MOVEMENT DISORDERS, 2013, 28 : S159 - S159
  • [27] Efficacy and safety of valbenazine in Japanese patients with tardive dyskinesia: A multicenter, randomized, double-blind, placebo-controlled study (J-KINECT)
    Horiguchi, Jun
    Watanabe, Koichiro
    Kondo, Kazuoki
    Iwatake, Atsushi
    Sakamoto, Hajime
    Susuta, Yutaka
    Masui, Hideaki
    Watanabe, Yumi
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2022, 76 (11) : 560 - 569
  • [28] Efficacy and Safety of Upadacitinib in a Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2/3 Clinical Study of Patients with Active Ankylosing Spondylitis
    van der Heijde, Desiree
    Song, In-Ho
    Pangan, Aileen
    Deodhar, Atul
    Van den Bosch, Filip
    Maksymowych, Walter P.
    Kim, Tae-Hwan
    Kishimoto, Mitsumasa
    Everding, Andrea
    Sui, Yunxia
    Wang, Xin
    Chu, Alvina D.
    Sieper, Joachim
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [29] A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Patients With IgA Nephropathy
    Rizk, Dana
    Perkovic, Vlado
    Lafayette, Richard A.
    Trimarchi, Hernan
    Barratt, Jonathan
    Carroll, Kevin
    Tesar, Vladimir
    Zhang, Hong
    Suzuki, Yusuke
    Liew, Adrian
    Wong, Muh Geot
    Leslie, Bruce R.
    Mathur, Mohit
    Hafkin, Jeffrey
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 799 - 799
  • [30] Efficacy and Safety of Imeglimin Monotherapy Versus Placebo in Japanese Patients With Type 2 Diabetes (TIMES 1): A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Phase 3 Trial
    Dubourg, Julie
    Fouqueray, Pascale
    Thang, Carole
    Grouin, Jean-Marie
    Ueki, Kohjiro
    DIABETES CARE, 2021, 44 (04) : 952 - 959
12345